The HARMONY Alliance will be participating in the Myeloma Patients Europe (MPE) Annual General Meeting on March 6–8, 2020, in Amsterdam. MPE is part of HARMONY’s Patient Cluster and plays a key role in ensuring HARMONY’s Myeloma research remains patient focused.
The MPE meeting will comprise a masterclass and general assembly, in which myeloma specialists from across Europe will deliver scientific sessions. There will also be a number of patient advocacy sessions that explore access to medicines and optimization of care across Europe.
HARMONY representative, Ana Rodríguez, IBSAL (Institute of Cancer Molecular and Cellular Biology, Spain), will be delivering a presentation on how the HARMONY Alliance uses Big Data to conduct research in blood cancers, including Multiple Myeloma. Details of the presentation:
Stay tuned for more details!
Watch this short video to learn how HARMONY uses Big Data in Myeloma and other blood cancers.
The MPE Annual General Meeting brings together patients, physicians, regulators and pharma representatives to discuss strategies for enabling patient-centered care. Click here to visit the official MPE meeting website.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!